(HCM) is characterized by hypertrophy of the myocardium and is associated with various clinical presentations ranging from complete absence of symptoms to sudden, unexpected death.
Keywords: Case report, Coronary artery-pulmonary artery fistula, Hypertrophic cardiomyopathy
, Cardiac MRI (CMR), Chest pain.
8] The diagnostic criteria for apical hypertrophic cardiomyopathy
included demonstration of asymmetric hypertrophy, confined predominantly to the apex with an apical wall thickness > 15 mm and a ratio of maximal apical to posterior wall thickness > 1.
The report provides a snapshot of the global therapeutic landscape of Hypertrophic Cardiomyopathy
(HCM) is a heterogeneous cardiac disease with a diverse clinical presentation and course.
3] Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW et al Tissue doppler imaging predicts the development of hypertrophic cardiomyopathy
in subjects with subclinical disease.
is a disease with an autosomal dominant pattern of transmission and variable penetrance.
What we're trying to do in these guidelines is to change a mind-set, because hypertrophic cardiomyopathy
is not really a diagnosis; it actually represents a family of diseases.
Conclusion: Hypertrophic cardiomyopathy
complicated with malignant ventricular arrhythmias can be well treated with low-dose amiodarone and Betaloc, with mitigated symptoms, improved prognosis and few adverse reactions.
This guide discusses the diagnosis and treatment of hypertrophic cardiomyopathy
for patients and healthcare providers, including its definition, history, prevalence, cause, symptoms, assessment, and when it develops.
Genetic variations of [beta]-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy
But an inquest revealed she had a condition known as hypertrophic cardiomyopathy
, where all the muscle wall of the heart becomes thickened.
He was "in effect dead" for 78 minutes after suffering a cardiac arrest and was later diagnosed with hypertrophic cardiomyopathy
(HCM) and spent weeks at the London Chest Hospital.
12 ( ANI ): Researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) is capable of delaying or preventing hypertrophic cardiomyopathy
, a type of a heart failure in which the heart muscle grows abnormally thick.
Camuglia AC, Younger JF, McGaughran J, Lo A, Atherton JJ (2013) Cardiac myosin-binding protein C gene mutation expressed as hypertrophic cardiomyopathy
and left ventricular noncompaction within two families: Insights from cardiac magnetic resonance in clinical screening: MYBPC3 gene mutation and MRI.